Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2020

Feb 25, 2020

30339_dirs_2020-02-25_e0467224-0813-46b2-883e-6768f689d19a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-02-23

Reporting Person: Favorite Annette F (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-23 Common Stock F 42.00 $170.16 Disposed 8208.9617 Direct

Footnotes

F1: Shares withheld to cover taxes related to Bonus and incentive shares granted on February 23, 2016.